Luteal Phase Deficiency (LPD)

By RRM Academy Reviewed by Dr. Naomi Whittaker, MD, Board-Certified OBGYN, MIGS, NFPMC, FCI Updated May 7, 2026

A reproductive condition characterized by inadequate progesterone production or insufficient duration of the luteal phase, impairing endometrial preparation for implantation and early pregnancy support. Causes include impaired follicular development leading to insufficient corpus luteum formation, hypothyroidism, hyperprolactinemia, and GnRH pulsatility disruption. NaPro diagnosis is based on cycle-timed progesterone measurements aligned to the Peak Day and Peak+3 through Peak+11 series. Treatment involves ovulation induction (to optimize follicular development and subsequent corpus luteum function) and/or progesterone supplementation beginning 3 to 4 days after the Peak. LPD is a treatable hormonal pattern. With accurate cycle charting and targeted intervention, normal luteal function is restored in most cases. When the deficit originates specifically from inadequate corpus luteum output, see Corpus Luteum Deficiency (CLD) for the mechanism and targeted treatment approach.⁴⁴⁴⁵

Hilgers identified five distinct LPD subtypes, each requiring a different treatment strategy.⁷⁸ Note that the NaPro post-Peak duration threshold is 8 days, not the older 11-day BBT-temperature-phase criterion from the Vollman/Jones era. That older standard measured a different endpoint from a different method. The 8-day post-Peak threshold applies here.

• Type I: Post-Peak phase of 8 days or fewer, combined with low end-luteal progesterone. Short luteal length with diminished hormone output throughout.
• Type II: Normal post-Peak duration, but suboptimal progesterone across the Peak+3 to Peak+11 window. Duration is adequate; integrated output is not.
• Type III: A late drop pattern defined by a 50% or greater fall in progesterone on Peak+9 or Peak+11 relative to the peak luteal value (Relative Progesterone Ratio below 50%). The corpus luteum collapses early before the luteal phase ends.
• Type IV: Early-luteal deficit with inadequate progesterone rise from Peak+3 to Peak+5. The corpus luteum fails to mount its initial output.
• Type V: Isolated luteal-phase estradiol deficit. Progesterone may be within range, but luteal estradiol is suboptimal. Treatment is Cooperative Estrogen Replacement Therapy (CERT). for progesterone-based protocols.

The Peak+3 progesterone marker anchors ovulation confirmation in NaPro practice. A result of 2.3 ng/mL or above confirms that ovulation has occurred. A result of 3.0 ng/mL or above indicates that an absolute period of postovulation infertility has begun. Values below these thresholds warrant evaluation for an ovulation disorder or early luteal deficit before any further cycle-timed treatment is planned. See Sonographic Ovulation Classification for the ultrasound correlates used alongside progesterone values to characterize ovulation quality.⁸¹

This content is for educational purposes only and does not constitute medical advice. Consult an RRM clinician or healthcare provider for guidance specific to your situation.